KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Work In Process (2016 - 2018)

Historic Work In Process for Teva Pharmaceutical Industries (TEVA) over the last 10 years, with Q4 2018 value amounting to $590.0 million.

  • Teva Pharmaceutical Industries' Work In Process fell 117.25% to $590.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $590.0 million, marking a year-over-year decrease of 117.25%. This contributed to the annual value of $590.0 million for FY2018, which is 117.25% down from last year.
  • According to the latest figures from Q4 2018, Teva Pharmaceutical Industries' Work In Process is $590.0 million, which was down 117.25% from $609.0 million recorded in Q3 2018.
  • Teva Pharmaceutical Industries' Work In Process' 5-year high stood at $646.0 million during Q1 2018, with a 5-year trough of $535.0 million in Q4 2015.
  • For the 5-year period, Teva Pharmaceutical Industries' Work In Process averaged around $594.8 million, with its median value being $601.0 million (2017).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Work In Process tumbled by 1614.42% in 2015 and then soared by 1096.65% in 2017.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Work In Process stood at $638.0 million in 2014, then fell by 16.14% to $535.0 million in 2015, then rose by 0.56% to $538.0 million in 2016, then grew by 10.97% to $597.0 million in 2017, then dropped by 1.17% to $590.0 million in 2018.
  • Its last three reported values are $590.0 million in Q4 2018, $609.0 million for Q3 2018, and $605.0 million during Q2 2018.